Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Millennium Article
  • Published:

Neurotransmitter transporters: fruitful targets for CNS drug discovery

Molecular Psychiatry volume 5, pages 357–362 (2000)Cite this article

Abstract

More than 20 members have been identified in the neurotransmitter transporter family. These include the cell surface re-uptake mechanisms for monoamine and amino acid neurotransmitters and vesicular transporter mechanisms involved in neurotransmitter storage. The norepinephrine and serotonin re-uptake transporters are key targets for antidepressant drugs. Clinically effective antidepressants include those with selectivity for either NE or serotonin uptake, and compounds with mixed actions. The dopamine transporter plays a key role in mediating the actions of cocaine and the amphetamines and in conferring selectivity on dopamine neurotoxins. The only clinically used compound to come so far from research on amino acid transporters is the antiepileptic drug tiagabine, a GABA uptake inhibitor.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Axelrod J, Weil-Malherbe H, Tomchick R . The physiological disposition of 3H-epinephrine and its metabolite metanephrine J Pharmacol Exp Ther 1959; 127: 251–256

    CAS  PubMed  Google Scholar 

  2. Whitby LG, Axelrod J, Weil-Malherbe H . The fate of 3H-norepinephrine in animals J Pharmacol Exp Ther 1961; 132: 193–201

    CAS  PubMed  Google Scholar 

  3. Hertting G, Axelrod J, Kopin IJ, Whitby LG . Lack of uptake of catecholamines after chronic denervation of sympathetic nerves Nature 1961; 189: 66

    Article  CAS  Google Scholar 

  4. Hertting G, Axelrod J . Fate of tritiated noradrenaline at the sympathetic nerve endings Nature 1961; 192: 172–173

    Article  CAS  Google Scholar 

  5. Iversen LL . Role of transmitter uptake mechanisms in synaptic neurotransmission Br J Pharmacol 1971; 41: 571–591

    Article  CAS  Google Scholar 

  6. Iversen LL . Uptake processes for biogenic amines. In: Iversen L, Iversen S, Snyder S (eds) Handbook of Psychopharmacology Vol 3: Plenum Press: New York 1975; pp381–432

    Google Scholar 

  7. Masson J, Sagné C, Hamon M, El Mestikawy S . Neurotransmitter transporters in the central nervous system Pharmacol Rev 1999; 51: 439–464

    CAS  PubMed  Google Scholar 

  8. Radian R, Kanner BI . Reconstitution and purification of the sodium-and chloride-coupled γ-aminobutyric acid transport glycoprotein from rat brain J Biol Chem 1986; 260: 11859–11865

    Google Scholar 

  9. Pacholczyk T, Blakely RD, Amara SG . Expression cloning of an antidepressant-sensitive noradrenaline transporter Nature 1991; 350: 350–353

    Article  CAS  Google Scholar 

  10. Gründemann D, Schechinger B, Rappold GA, Schömig E . Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter Nature Neurosci 1998; 1: 349–351

    Article  Google Scholar 

  11. Wahle S, Stoffel W . Membrane topology of the high affinity L-glutamate transporter (GLAST-1) of the central nervous system J Biol Chem 1996; 135: 1867–1877

    CAS  Google Scholar 

  12. Kavanaugh MP . Neurotransmitter transport: models in flux Proc Natl Acad Sci USA 1998; 95: 12737–12738

    Article  CAS  Google Scholar 

  13. Axelrod J, Whitby L, Hertting G . Effect of psychotropic drugs on the uptake of 3H-norepinephrine by tissues Science 1961; 133: 383

    Article  CAS  Google Scholar 

  14. Healy D . The Antidepressant Era Harvard University Press: Boston 1998

    Google Scholar 

  15. Wong DT, Bymaster FP, Engleman EA . Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug. Twenty years since its first publication Life Sci 1995; 57: 411–441

    Article  CAS  Google Scholar 

  16. Owens MJ, Morgan WN, Plott SJ, Nemeroff CB . Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites J Pharmacol Exp Ther 1997; 283: 1305–1322

    CAS  PubMed  Google Scholar 

  17. Chustecka Z . New challenges in the antidepressant market SCRIP 1998; 2356: 24–25

    Google Scholar 

  18. Heal DJ, Aspley S, Prow MR, Jackson HC, Martin KF, Cheetham SC . Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine Int J Obes Relat Metab Disord 1998; 22 Suppl 1: S18–S28

    CAS  Google Scholar 

  19. Montgomery S . Reboxetine: additional benefits to the depressed patient J Psychopharmacol 11 Suppl 4: S9–S15

  20. Ressler KJ, Nemeroff CB . Role of norepinephrine in the pathophysiology and treatment of mood disorders Biol Psychiatry 1999; 46: 1219–1233

    Article  CAS  Google Scholar 

  21. Schildkraut J . The catecholamine hypothesis of affective disorders: a review of supporting evidence Am J Psychiatry 1965; 122: 509–522

    Article  CAS  Google Scholar 

  22. Al-Damluji S, Kopin IJ . Functional properties of the uptake of amines in immortalised peptidergic neurones (transport-P) Br J Pharmacol 1996; 117: 111–118

    Article  CAS  Google Scholar 

  23. Al-Damluji S, Kopin IJ . Binding and competitive inhibition of amine uptake at postsynaptic neurones (transport-P) by tricyclic antidepressants Br J Pharmacol 1996; 117: 811–816

    Article  CAS  Google Scholar 

  24. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG . Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 1996; 379: 606–612

    Article  CAS  Google Scholar 

  25. Rocha BA, Fumagalli F, Gainetdinov RR, Jones SR, Ator R, Giros B et al. Cocaine self-administration on dopamine transporter knockout mice Nature Neurosci 1998; 1: 132–137

    Article  CAS  Google Scholar 

  26. Sora I, Wichems C, Takahashi N, Li XF, Zeng Z, Revay R et al. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice Proc Natl Acad Sci USA 1998; 95: 7699–7704

    Article  CAS  Google Scholar 

  27. Graul A, Castaner J . Brasofensine sulfate: antiparkinsonian dopamine reuptake inhibitor Drugs of the Future 1999; 24: 128–132

    Article  Google Scholar 

  28. Solanto MV . Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration Behav Brain Res 1998; 94: 127–152

    Article  CAS  Google Scholar 

  29. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG . Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity Science 1999; 283: 397–401

    Article  CAS  Google Scholar 

  30. Cook EH, Stein MA, Krasowski MD, Cox W, Olkon DM, Kieffer JE et al. Association of attention-deficit disorder and the dopamine transporter gene Am J Hum Genet 1995; 56: 993–998

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Luer MS, Rhoney-Denise H . Tiagabine: a novel antiepileptic drug Annal Pharmacother 1998; 32: 1173–1180

    Article  CAS  Google Scholar 

  32. Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, Piomelli D . Functional role of high-affinity anandamide transport, as revealed by selective inhibition Science 1997; 277: 1094–1097

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK

    L Iversen

Authors
  1. L Iversen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iversen, L. Neurotransmitter transporters: fruitful targets for CNS drug discovery. Mol Psychiatry 5, 357–362 (2000). https://doi.org/10.1038/sj.mp.4000728

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4000728

Keywords

This article is cited by

Search

Advanced search

Quick links